Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

The preparation method of dabrafenib

A technology of fluorophenyl, alkyl propionate, applied in the field of preparation of dabrafenib, can solve the problems of harsh reaction conditions, many reaction steps, difficult post-processing, etc., achieves controllable production, improved product quality, and increased atomic economical effect

Active Publication Date: 2016-01-20
中铁装配式建筑科技有限公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Considering the above two synthetic routes A and B, although the target product can be prepared, there are still defects such as many reaction steps, difficult post-processing and harsh reaction conditions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of dabrafenib
  • The preparation method of dabrafenib
  • The preparation method of dabrafenib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Add 3-(3-amino-2-fluorophenyl)-3-oxa-propionic acid ethyl ester (II) (11.3g, 50mmol), pyridine 10mL, catalytic amount of 4-dimethylaminopyridine into the three-necked flask (DMAP) and dichloromethane 200mL, after stirring and dissolving, add dropwise 2,6-difluorobenzenesulfonyl chloride (III) (11.7g, 55mmol) in dichloromethane 50mL solution at 0°C, after dropping, react at room temperature for 16 After 1 hour, TLC detected that the reaction was over. Add water to wash, and the obtained organic phase is washed with brine, dried over anhydrous sodium sulfate, and the solvent is recovered by distillation under reduced pressure. The obtained crude product is washed with petroleum ether to obtain an off-white solid 3-[3-(2,6-difluorobenzenesulfonamide 12.4 g of ethyl)-2-fluorophenyl]-3-oxa-propionic acid (IV), and the yield was 60.5%.

Embodiment 2

[0032] To 3-[3-(2,6-difluorobenzenesulfonamido)-2-fluorophenyl]-3-oxa-propionic acid ethyl ester (IV) (10g, 25mmol) and dichloromethane 150mL was added N-bromosuccinimide (NBS) (8.9 g, 50 mmol), the resulting red solution was stirred at room temperature for 30 minutes, then concentrated under reduced pressure, and the obtained residue was dissolved in 100 mL of dioxane. Magnesium carbonate (2.1, 25mmol) and 2,2-dimethylthiopropionamide (VI) (3.5g, 30mmol) were added to the solution, and after stirring at room temperature for 4 hours, the reaction was quenched with water and 1N hydrochloric acid, and The reaction was stirred for 0.5 hours. Filtration, the resulting solid was recrystallized from ethyl acetate and n-hexane (1:1) to give white solid N-[3-[5-ethyl carboxylate-2-(tert-butyl)-4-thiazolyl]-2-fluoro 7.25 g of phenyl]-2,6-difluorobenzenesulfonamide (VII), the yield is 58.2%.

Embodiment 3

[0034] Add N-[3-[5-ethyl carboxylate-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide (VII) into the reaction flask (6.0g, 12mmol), sodium methoxide (0.81g, 15mmol) and anhydrous ethyl acetate 50mL. Stir at room temperature for 1 hour, heat up to 80°C, reflux for 5 hours, cool down, and stand at room temperature for 12 hours. Add 100 mL of water, add 50 mL of concentrated hydrochloric acid under stirring, heat up to reflux, and react for 4 hours. TLC detects that the reaction is complete. The pH was adjusted to 9-10 with 2M sodium hydroxide. Extracted 3 times with chloroform, combined the organic phases, dried over anhydrous sodium sulfate, and recovered the solvent by distillation under reduced pressure to obtain the product N-[3-(5-acetyl-2-tert-butyl-4-thiazolyl)-2-fluoro 5.4 g of phenyl]-2,6-difluorobenzenesulfonamide (VIII). It can be directly used in the following reaction without purification.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of dabrafenib, which comprises the following steps of taking 3-(3-amino-2-fluorophenyl)-3-oxa-propionate (II) as a raw material, and performing sulfamidation, halogenation, thiazole cyclization, acylation, pyrimidine cyclization and the like to form the dabrafenib (I). The raw material is easy to obtain, the preparation method is concise in technology and mild in condition, is applicable to industrial production, and promotes economic and technical development of the dabrafenib.

Description

technical field [0001] The invention belongs to the technical field of organic synthesis route design and preparation of raw materials and intermediates, and in particular relates to a dabrafenib preparation method. Background technique [0002] Dabrafenib is a serine-threonine-protein kinase (BRAF) inhibitor developed by GlaxoSmithKline (GSK), UK, as a single-drug oral capsule for surgically unresectable patients with BRAFV600E mutation For the treatment of adult patients with melanoma or metastatic melanoma, dabrafenib mesylate was approved by the U.S. Food and Drug Administration (FDA) in May 2013, and it is listed in the U.S. under the trade name Tafinlar. . Due to the positive evaluation of Tafinlar by the Human Medicinal Products Committee (CHMP) of the European Medicines Agency (EMA), the drug is expected to become the second BRAF inhibitor to enter the European market after Roche's Vemurafinib. [0003] The chemical name of dabrafenib is: N-[3-[5-(2-amino-4-pyrimid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D417/04
CPCC07D417/04
Inventor 许学农
Owner 中铁装配式建筑科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com